Eisai Co., Ltd. has decided to shut down its US research subsidiary H3 Biomedicine Inc in September as part of a wider restructuring of its global R&D organization.
According to an official notice of layoffs published by the state of Massachusetts, where H3 is located, 79 employees will be laid off in connection with the decision
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?